Child-Parent Familial Hypercholesterolemia Screening
Launched by CHILDREN'S HOSPITAL OF FUDAN UNIVERSITY · Aug 25, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a way to screen young children and their parents for a condition called familial hypercholesterolemia (FH), which can lead to high cholesterol levels and increase the risk of heart disease at an early age. The researchers want to find out how effective and practical it is to check for this condition in a regular doctor's office. They are particularly interested in understanding the cholesterol levels in 2-year-old children and identifying specific genetic changes that might lead to high cholesterol.
If you have a child between 1 and 3 years old who receives routine healthcare, they might be eligible to participate. However, the researchers will decide who can join based on specific health details. Participants can expect to have their cholesterol levels tested, and the study aims to help doctors better identify families at risk for heart issues in the future. This trial is not yet recruiting participants, so there will be more information available soon for interested families.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Receive routine child care
- • aged 1 - 3 years old ( date of investigate minus date of birth)
- Exclusion Criteria:
- • It is up to the researcher to decide whether it is suitable to participate in this research
About Children's Hospital Of Fudan University
The Children's Hospital of Fudan University is a leading pediatric healthcare institution in China, renowned for its commitment to advancing child health through innovative research and clinical excellence. As a prominent clinical trial sponsor, the hospital focuses on conducting high-quality, ethically-driven studies that aim to improve pediatric care and treatment outcomes. With a multidisciplinary team of experienced healthcare professionals and researchers, the hospital leverages its robust infrastructure and expertise to facilitate groundbreaking clinical trials, ensuring the safety and well-being of child participants while contributing valuable insights to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hefei, Anhui, China
Qidong, Jiangsu, China
Taiyuan, Shan Xi, China
Shanghai, Shanghai, China
Chongqing, Sichuan, China
ürümqi, Xinjiang, China
Patients applied
Trial Officials
LIling Qian, Master
Study Director
Children's Hospital of Fudan University
Rui Dong, MD
Study Director
Children's Hospital of Fudan University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials